1178 completed, 369 unknown, 187 recruiting, 155 terminated. 482 Not applicable, 296 Phase 3, 222 Phase 4, 218 Phase 2, 125 Phase 1.
Follow Thrombosis: new trials by email Literature Review of Thrombosis trials Research Report on Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SAFELY RULING OUT DEEP VEIN THROMBOSIS IN PREGNANCY WITH THE LEFt SCORE AND TRIMESTER-ADJUSTED D-DIMER CUTOFFS (the PREG-DVT Study): A PROSPECTIVE COHORT STUDY. D-dimer - Pregnancy Related, Deep Vein Thrombosis | Not applicable | Not yet recruiting | Marc Righini | 330 | 2027-04-01 | 2026-10-21 |
| Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients Quantra System - Pediatric, Coagulation | Not yet recruiting | HemoSonics LLC | 240 | 2027-03-15 | 2026-09-17 | |
| Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease BOTOX INJECTION - Buerger Disease, Raynaud Syndrome | Phase 3 | Not yet recruiting | University Hospital, Toulouse | 8 | 2027-01-01 | 2026-07-23 |
| Anticoagulant Cessation After Antiphospholipid Autoantibodies Loss in Thrombotic Antiphospholipid Syndrome Vitamin K Antagonist - Drug, Anticoagulant Therapy Discontinuation - Antiphospholipid Syndrome, Thrombotic Antiphospholipid Syndrome | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 234 | 2026-12-01 | 2026-10-15 |
| LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus Continue rivaroxaban or apixaban or warfarin, Discontinue rivaroxaban or apixaban or warfarin - Left Ventricular Thrombus | Phase 2 | Not yet recruiting | Queen Mary University of London | 120 | 2026-12-01 | 2026-02-27 |
| Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism edoxaban, Apixaban - Venous Thromboembolism, Active Cancer | Phase 4 | Not yet recruiting | Samsung Medical Center | 2300 | 2026-11-01 | 2026-10-01 |
| Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF) blood sampling for measuring anti-Xa activity, measurement of anti-XA activity - Congenital Heart Disease, Unfractionated Heparin | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de la Réunion | 22 | 2026-11-01 | 2026-09-21 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks LIQ861 (treprostinil) inhalation powder - Dose Titration Arm, LIQ861 (treprostinil) inhalation powder - fixed dose arm - Raynaud's Phenomenon Secondary to Systemic Sclerosis | Phase 2 | Not yet recruiting | Liquidia Technologies, Inc. | 75 | 2026-10-26 | 2026-08-07 |
| TOF-MRV Versus Post-Contrast 3D T1 MRI in Dural Venous Sinus Thrombosis Cerebral Thrombosis, Venous Thrombosis | Not yet recruiting | Assiut University | 80 | 2026-10-20 | 2026-10-22 | |
| "IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ" Anakinra 100Mg/0.67Ml Inj Syringe - Pancreatic Transplant | Phase 1 / Phase 2 | Recruiting | Nantes University Hospital | 15 | 2026-10-07 | 2026-10-13 |
| The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study GORE® VIABAHN® FORTEGRA Venous Stent - Venous Thromboses, Venous Disease | Not applicable | Not yet recruiting | W.L.Gore & Associates | 150 | 2026-10-07 | 2026-08-12 |
| Vflower Stent System for Iliofemoral Vein Stenosis and Occlusion: A Multicenter Real-World Study Vflower venous stent system (self-expanding nitinol stent for iliofemoral venous lesions) - Iliofemoral Vein Stenosis, Iliofemoral Vein Occlusion | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 310 | 2026-10-01 | 2026-09-09 | |
| Investigating a Personalized Approach to Anti-Platelet Therapy Genotyping guided therapy for anti-platelet management - High Risk Bleeding | Phase 4 | Not yet recruiting | Ottawa Heart Institute Research Corporation | 1760 | 2026-10-01 | 2026-09-08 |
| Regulation of Platelet Function in Older Patients With Atrial Fibrillation Atrial Fibrillation, Thrombotic Risk | Not yet recruiting | University of Michigan | 50 | 2026-10-01 | 2026-09-25 | |
| Efficacy and Safety of Peripherally Inserted Central Venous Catheters Critical Illness, Catheter-Related Infections | Not yet recruiting | Assiut University | 60 | 2026-10-01 | 2026-09-22 | |
| Safely Quenching Complement in Stroke Survivors Pegcetacoplan Injection [Empaveli] - Acute Ischemic Stroke, Cerebral Infarction | Phase 1 | Not yet recruiting | Columbia University | 20 | 2026-10-01 | 2026-04-29 |
| Changes in Intraocular Pressure After Intravitreal Injection Diabetic Macular Edema, Neovascular Age-Related Macular Degeneration | Not yet recruiting | Assiut University | 50 | 2026-10-01 | 2026-09-17 | |
| Iopidine to Decrease Intraocular Pressure Rise After Injections Apraclonidine 1.0% ophthalmic solution - Macular Degeneration, Diabetic Retinopathy | Phase 4 | Not yet recruiting | Retina Consultants of Delmarva | 120 | 2026-10-01 | 2026-10-23 |
| The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry Recanalization and debulking - Chronic Venous Disease, Chronic Venous Insufficiency, CVI | Not yet recruiting | Intervene, Inc. | 500 | 2026-10-01 | 2026-10-23 |
Showing 20 of 2073. Sign in to see all of them.
Venous Thrombosis (763) · Pulmonary Embolism (325) · Retinal Vein Occlusion (275) · Venous Thromboembolism (233) · Hemorrhage (122) · Macular Edema (113) · Atrial Fibrillation (82) · Stroke (81) · Raynaud Disease (80) · Postthrombotic Syndrome (72) · Cardiovascular Diseases (67) · Thromboembolism (66) · COVID-19 (65) · Neoplasms (62)
Vascular Diseases (2051) · Embolism and Thrombosis (2047) · Cardiovascular Diseases (2006) · Pathological Conditions, Signs and Symptoms (566) · Pathologic Processes (511) · Respiratory Tract Diseases (408) · Lung Diseases (394) · Venous Thrombosis (341) · Embolism (317) · Eye Diseases (275) · Retinal Diseases (260) · Thromboembolism (229) · Heart Diseases (228) · Nervous System Diseases (205)
Enoxaparin (97) · Rivaroxaban (94) · Warfarin (66) · apixaban (61) · Ranibizumab (60) · Aspirin (58) · Heparin (46) · Blood Specimen Collection (40) · Heparin, Low-Molecular-Weight (39) · Clopidogrel (34) · aflibercept (34) · Dalteparin (31) · edoxaban (26) · Fondaparinux (25) · Dexamethasone (22)
Bayer (35) · Bristol-Myers Squibb (28) · Assistance Publique - Hôpitaux de Paris (21) · Brigham and Women's Hospital (21) · Ottawa Hospital Research Institute (21) · HemoSonics LLC (19) · Novartis Pharmaceuticals (19) · Allergan (16) · McMaster University (16) · Assiut University (15) · Johns Hopkins University (14) · National Heart, Lung, and Blood Institute (NHLBI) (14) · Sanofi (14) · Centre Hospitalier Universitaire de Saint Etienne (13) · Medical University of Vienna (13)
United States (645) · France (264) · Canada (197) · China (159) · Italy (145) · United Kingdom (145) · Germany (135) · Spain (106) · Netherlands (96) · Denmark (78) · Austria (73) · Israel (73) · Belgium (68) · Switzerland (67) · Australia (65)
Samuel Z. Goldhaber, MD (6) · Mark A Crowther, MD (5) · Amanda L Hunter, MBChB (4) · Christopher Puccini, MD (4) · David E Newby, MD PhD (4)
PMID 35244208, PMID 39968829, PMID 33502773, PMID 33779986, PMID 38189593, PMID 35570249, PMID 36912792, PMID 33086312, PMID 37591523, PMID 37929840, PMID 23629822, PMID 32633861, PMID 40163217, PMID 19017588, PMID 20860504, PMID 22172244, PMID 22863355, PMID 23279103, PMID 23306310, PMID 23415775, PMID 23699977, PMID 23808982, PMID 23991658, PMID 24667535, PMID 24876082, PMID 25677668, PMID 26853645, PMID 26867832, PMID 27836513, PMID 27900179, PMID 27959702, PMID 27980462, PMID 28219692, PMID 28617144, PMID 28762617, PMID 29037354, PMID 29211671, PMID 29452956, PMID 29622159, PMID 29649055, PMID 31630479, PMID 31977000, PMID 31986264, PMID 32407672, PMID 33201130, PMID 33337539, PMID 33464575, PMID 34622445, PMID 34934034, PMID 35596679
2016 (7), 2018 (7), 2009 (6), 2015 (6), 2008 (5), 2019 (5), 2023 (5), 2025 (5), 2014 (4), 2005 (3), 2017 (2), K23HL132054 (2), R01HL114405 (2), 1UG1EY026876-01A1 (1), 1UG1EY028517-01 (1)